ADI-270CD70+ malignanciesNishimoto et al
…e adaptation of these engineering approaches to Vδ1 γδ T cells (ADI-270) by coexpressing a CD70-targeted CAR and a dominant-negative TG…
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: ADI-270 ×
ADI-270
This drug is selected. Its supporting articles are shown below.